U.S. Global Investors (USGI)’s Phibro Animal Health PAHC Stock Holding History

U.S. Global Investors (USGI)’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-26,189	Closed	-$832K	–	192
2019 Q2	$832K	Buy	+26,189	New	+$821K	0.43%	65
2019 Q1	–	Sell	-22,044	Closed	-$709K	–	187
2018 Q4	$709K	Sell	22,044 -430	-2%	-$16.2K	0.41%	74
2018 Q3	$964K	Sell	22,474 -10,526	-32%	-$497K	0.47%	65
2018 Q2	$1.52M	Hold	33,000	–	–	0.69%	36
2018 Q1	$1.31M	Buy	33,000 +9,100	+38%	+$337K	0.81%	33
2017 Q4	$801K	Sell	23,900 -5,000	-17%	-$178K	0.37%	62
2017 Q3	$1.07M	Buy	+28,900	New	+$1.09M	0.32%	70
2017 Q2	–	Sell	-34,300	Closed	-$964	–	172
2017 Q1	$964	Sell	34,300 -11,700	-25%	-$330K	﹤0.01%	69
2016 Q4	$1.35M	Buy	+46,000	New	+$1.26M	0.57%	42

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

FIM

Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

U.S. Global Investors (USGI)'s PAHC Position: Q3 2019 in Review

U.S. Global Investors (USGI) sold out of Phibro Animal Health (PAHC) in Q3 2019, closing a stake of 26,189 shares — an estimated $832K sold.

U.S. Global Investors (USGI) first reported a position in PAHC in Q4 2016 and held it in 9 quarters. The position peaked at $1.52M in Q2 2018. 153 funds tracked by Wall St. Rank hold PAHC as of Q3 2019.

U.S. Global Investors (USGI) reported no remaining Phibro Animal Health position as of Q3 2019 after selling out during the quarter.
U.S. Global Investors (USGI) sold 26,189 Phibro Animal Health shares in Q3 2019, an estimated $832K.
U.S. Global Investors (USGI) first reported a position in Phibro Animal Health in Q4 2016 and held it in 9 quarters.
U.S. Global Investors (USGI)'s Phibro Animal Health position peaked at $1.52M in Q2 2018.
153 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2019.

Based on U.S. Global Investors (USGI)'s 13F filing for Q3 2019, filed 12 Nov 2019.